| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/24/2011 | CA2774154A1 Immunological compositions for hiv |
| 03/24/2011 | CA2774053A1 Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof |
| 03/24/2011 | CA2773999A1 Gene expressing a bifidobacterium surface-presented fusion protein |
| 03/24/2011 | CA2773552A1 Treatment of neurological conditions |
| 03/24/2011 | CA2771336A1 Synergistic anti-cd47 therapy for hematologic cancers |
| 03/23/2011 | EP2299272A2 N-terminally truncated HER-2/NEU protein as a cancerprognostic indicator |
| 03/23/2011 | EP2298934A1 S. pneumoniae antigens |
| 03/23/2011 | EP2298927A2 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 03/23/2011 | EP2298924A2 Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA |
| 03/23/2011 | EP2298910A1 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof |
| 03/23/2011 | EP2298900A1 Compositions and methods for treating intracellular diseases |
| 03/23/2011 | EP2298877A1 Compounds for immunotherapy of prostate cancer and methods for their use |
| 03/23/2011 | EP2298860A2 Method of producing rough strains of bacteria and uses thereof |
| 03/23/2011 | EP2298817A1 Hybrid antibodies |
| 03/23/2011 | EP2298816A2 Apoptosis induced by an antibody against Her2 |
| 03/23/2011 | EP2298815A1 B-cell reduction using CD37-specific and CD20-specific binding molecules |
| 03/23/2011 | EP2298813A2 Anti-TRKB monoclonal antibodies and uses thereof |
| 03/23/2011 | EP2298812A2 Remedies for juvenile chronic arthritis and related diseases |
| 03/23/2011 | EP2298811A2 Human anti-ifn-gamma neutralizing antibodies as selective ifn-gamma pathway inhibitors |
| 03/23/2011 | EP2298810A2 Treatment of TNF alpha related disorders |
| 03/23/2011 | EP2298809A2 Super humanized antibodies |
| 03/23/2011 | EP2298808A1 Anti-C5 antibodies and their therapeutic uses |
| 03/23/2011 | EP2298806A1 Antibodies that bind cell-associated CA 125/0722P and methods of use thereof |
| 03/23/2011 | EP2298805A2 Optimized Fc variants and methods for their generation |
| 03/23/2011 | EP2298804A2 Monoclonal antibody production by EBV transformation of B cells |
| 03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof |
| 03/23/2011 | EP2298796A2 Staphylococcus aureus proteins and nucleic acids |
| 03/23/2011 | EP2298793A2 Polypeptide fragments of hepatitis E virus, vaccine composition comprising said fragments and diagnostic kits |
| 03/23/2011 | EP2298789A1 Mammalian genes; related reagents and methods |
| 03/23/2011 | EP2298717A1 Antibodies against monocyte chemotactic proteins |
| 03/23/2011 | EP2298355A2 Albumin fusion proteins |
| 03/23/2011 | EP2298354A2 Remodelling and glycoconjugation of interferon-beta |
| 03/23/2011 | EP2298348A1 Antibody binding alpha4Beta7 integrin and its use to treat inflammatory bowel disease |
| 03/23/2011 | EP2298347A1 Clotting factor VII-Fc chimeric proteins for treatment of a hemostatic disorder |
| 03/23/2011 | EP2298346A2 Human antibodies specific to kdr and uses thereof |
| 03/23/2011 | EP2298344A1 Use of inactivated japanese encephalitis virus particle as adjuvant |
| 03/23/2011 | EP2298343A1 Composition and method for increasing cell density in cell cultures infected with lentivirus |
| 03/23/2011 | EP2298342A2 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 03/23/2011 | EP2298341A2 Iimmunogenic compositions of staphylococcus epidermidis polypeptide and polynucleotide antigens |
| 03/23/2011 | EP2298340A1 Immunogenic composition for use in vaccination against staphylococcei |
| 03/23/2011 | EP2298339A1 Treating neoplasms with neurotoxin |
| 03/23/2011 | EP2298334A2 Tweak receptor |
| 03/23/2011 | EP2298333A2 Tweak receptor |
| 03/23/2011 | EP2298332A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 03/23/2011 | EP2298327A1 Anti-tumor agent |
| 03/23/2011 | EP2298304A2 Carboline derivatives useful in the treatment of cancer |
| 03/23/2011 | EP2298299A2 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 03/23/2011 | EP2297578A2 Vaccine assays |
| 03/23/2011 | EP2297309A1 Pestivirus replicons providing an rna-based viral vector system |
| 03/23/2011 | EP2297308A2 Anti-tumoral cells |
| 03/23/2011 | EP2297206A1 Anti-cxcr4 antibodies |
| 03/23/2011 | EP2297204A2 Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells |
| 03/23/2011 | EP2297187A1 A vaccine for the prevention and therapy of hcv infections |
| 03/23/2011 | EP2297186A2 Expression and assembly of human group c rotavirus-like particles and uses thereof |
| 03/23/2011 | EP2297185A1 Parvoviral capsid with incorporated gly-ala repeat region |
| 03/23/2011 | EP2296705A1 Ccl20-specific antibodies for cancer therapy |
| 03/23/2011 | EP2296704A1 Mechanism of action of primary cell derived biologic |
| 03/23/2011 | EP2296703A2 Igf-ii/gf-iie binding proteins |
| 03/23/2011 | EP2296702A1 Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant |
| 03/23/2011 | EP2296701A1 Cell-based systems for producing influenza vaccines |
| 03/23/2011 | EP2296700A2 Intranasal administration of receptor-binding ligands or genes encoding such ligands as a therapeutic regimen for mitigating infections caused by respiratory pathogens |
| 03/23/2011 | EP2296699A1 Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof |
| 03/23/2011 | EP2296698A1 Coccidiosis vaccines |
| 03/23/2011 | EP2296697A1 Immunogenic peptides derived from the midkine protein, as an anticancer vaccine |
| 03/23/2011 | EP2296696A1 Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| 03/23/2011 | EP2084190B1 Lingo binding molecules and pharmaceutical use thereof |
| 03/23/2011 | EP2040749B1 Pharmaceutical compositions containing monoclonal anti idiotypic anti-ca-125 antibody and aluminium |
| 03/23/2011 | EP1912673B1 Process for attaching effector molecules to proteins |
| 03/23/2011 | EP1552462B1 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 03/23/2011 | EP1469878B1 Fgfr agonists |
| 03/23/2011 | EP1463529B9 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 03/23/2011 | EP1351707B1 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 03/23/2011 | EP1320377B1 Hla binding peptides and their uses |
| 03/23/2011 | CN1922316B Mutants of anti-cd40 antibody |
| 03/23/2011 | CN101990548A Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions |
| 03/23/2011 | CN101990545A Peptide analogues and conjugates thereof |
| 03/23/2011 | CN101990439A Binding peptides having a c-terminally disposed specific binding domain |
| 03/23/2011 | CN101988071A Hepatitis c virus vaccine |
| 03/23/2011 | CN101988070A White spot syndrome virus VP292 polypeptide and application thereof |
| 03/23/2011 | CN101988069A Eimeria tenella heat shock protein 60 gene as well as cloning, expression and application thereof |
| 03/23/2011 | CN101988067A Prion isomer monoclonal antibody gene and application thereof |
| 03/23/2011 | CN101988058A Gene expression composition, PRRS (Porcine Reproductive and Respiratory Syndrome) oral vaccine and preparation methods thereof |
| 03/23/2011 | CN101987871A Optimized fc variants and methods for their generation |
| 03/23/2011 | CN101514334B Chicken infectivity bronchitis virus attenuated vaccine strain and application thereof |
| 03/23/2011 | CN101392261B Modified highly pathogenic porcine reproductive and respiratory syndrome virus ORF5 gene and application |
| 03/22/2011 | US7910716 Nucleic acids encoding modified South African HIV-1 subtype C gag proteins |
| 03/22/2011 | US7910708 Interleukin-13 specific immunoglobulin for treatment of asthma, skin, vision, inflammatory, cell proliferative, fibrotic and allergic disorders |
| 03/22/2011 | US7910707 Anti-interferon-α antibodies |
| 03/22/2011 | US7910704 Human p53 splice variant displaying differential transcriptional activity |
| 03/22/2011 | US7910564 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant |
| 03/22/2011 | US7910562 Method of delivering genes into antigen presenting cells of the skin |
| 03/22/2011 | US7910551 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 03/22/2011 | US7910548 Methods for treating obesity |
| 03/22/2011 | US7910370 Treating and preventing cell proliferative, neurodegenerative and viral infections via enhancing oncogenic protein expression |
| 03/22/2011 | US7910368 Method of extended culture for antigen-specific cytotoxic lymphocytes |
| 03/22/2011 | US7910330 Preparing messenger RNA coding plasmodial apical membrane antigen for developing malarial vaccine |
| 03/22/2011 | US7910329 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 03/22/2011 | US7910117 Vaccine |
| 03/22/2011 | US7910116 Use of a botulinum toxin to improve gastric emptying and/or to treat GERD |
| 03/22/2011 | US7910115 Polypeptide absorbable into digestive organs |